期刊文献+

PSA、ECT骨显像诊断前列腺癌骨转移的临床意义 被引量:2

Clinical significance of PSA and ECT in diagnosis of prostate cancer with bone metastasis
下载PDF
导出
摘要 目的:探讨前列腺特异抗原(PSA)、发射型计算机断层扫描(ECT)99Tc-MDP骨显像诊断前列腺癌骨转移的临床意义。方法:对80例(骨转移组31例,非骨转移组49例)前列腺癌病人的PSA、ECT与骨转移的关系进行回顾性分析。结果:骨转移组与非骨转移组的PSA值差异有显著性(139.36μg/Lvs37.58μg/L,P<0.01);PSA与骨转移的程度正相关,PSA<10μg/L,骨转移率为15.38%;PSA<20μg/L,骨转移率为19.35%;PSA>20μg/L,骨转移率为51.02%;PSA>100μg/L,骨转移率为78.95%。结论:ECT骨显像对前列腺癌骨转移有较高的敏感性,对未经治疗的前列腺癌病人,PSA<10μg/L,前列腺癌骨转移的可能性极小;PSA>100μg/L者,骨转移的可能性极大。PSA>20μg/L,建议行ECT骨扫描。 Objective:To evaluate the clinical significance of PSA and ECT bone scans in the diagnosis of bone metastasis in prostate cancer patients. Methods: Eighty cases of postate cancer were reviewed, bone metastasis (BM) occurred in 31 cases, and 49 cases without BM (NBM). The relation between PSA, ECT and bone metastasis was analyzed. Results: The value of PSA between BM and NBM groups had significant difference (139.36μg/L vs 37.58μg/L, P〈0.01). PSA and the degree of bone metastasis was positively correlated. PSA〈10μg/L, the morbidity of BM was 15.38%; PSA〈20μg/L, 19.35%%; PSA 〉20μg/L, 51.02%%; and PSA〉100μg/L, 78.95%. Conclusion: ECT is a high sensitive method in diagnosis for bone metastasis of prostate cancer. As for those patients of protate cancer without any treatment, while PSA〈10μg/L, the morbidity of BM is rare; while PSA〉100μg/L,BM is in high suspect. It should be suggested to make the bone scanning when the PSA 〉20μg/L.
出处 《现代肿瘤医学》 CAS 2007年第9期1293-1295,共3页 Journal of Modern Oncology
关键词 前列腺肿瘤 骨转移 前列腺特异抗原 发射型计算机断层扫描 prostate cancer bone metastasis emission computed tomography prostate specific antigen
  • 相关文献

参考文献9

  • 1Van den ouden D,Schroder FH.Management of locally advanced prostate cancer.staging,natural history,and results of radical surgery[J].World J Urol,2000,18:194 -203.
  • 2肖序仁,史立新,王晓雄,洪宝发,叶林阳,张磊,蔡伟,高江平,卢锦山,李炎唐.317例前列腺癌诊断分析[J].中华泌尿外科杂志,2002,23(9):540-544. 被引量:22
  • 3Schroder FH,Wildhagen MF,ERS PC.Screening for prostate cancer:evidence and perspectives[J].BJU Int,2001,88:811 -817.
  • 4姜昊文,张元芳,邓守真,管一晖.PSA诊断前列腺癌骨转移的临床价值[J].中华泌尿外科杂志,1999,20(2):99-101. 被引量:20
  • 5梅骅.前列腺癌的临床诊断[J].中华泌尿外科杂志,1997,18(2):119-122. 被引量:31
  • 6鲍镇美.前列腺癌的诊断[J].中华泌尿外科杂志,2000,21(4):253-256. 被引量:28
  • 7Shreve,Grossman H,Gross M,et al.Metastatic prostate cancer:initial findings of PET with 2 deoxy 2[f18] fluoro D glucose[J].Radiology,1996,199 (3):751 - 756.
  • 8Birtle A J,Freeman A,Masters J R,et al.Clinical features of pa tients who present with metastatic prostate carcinoma and serum prostate specific antigen(psa) levels < 10μg/L:the "PSA negative" patients[J].Cancer,2003,98 (11):2362 - 2367.
  • 9季鸿,于建芳,袁志斌,朱瑞森.血清BAP和PSA测定在前列腺癌骨转移诊断中的价值[J].核技术,2005,28(4):309-312. 被引量:9

二级参考文献18

  • 1鲍镇美,中华泌尿外科杂志,1997年,18卷,315页
  • 2梅骅,中华泌尿外科杂志,1997年,18卷,119页
  • 3郑思竞,系统解剖学(第3版),1989年,250页
  • 4Soloway M S, Hardeman S W, Hickey D, et al. Cancer,1992, 62:195-202.
  • 5Haeckel C, Ayala A G, Rading K, et al. Arch Pathol Lab Med, 1999, 123:213-221.
  • 6Gutman E B, Sproul E E, Gutman A B, et al. Am J Cancer,1936, 28:485-495.
  • 7Price C P. Ann Clin Biochem, 1993, 30:355-372.
  • 8Overguard K, Alexandersen P, Riis B J, et al. Clin Chem,1996, 42:973-974.
  • 9Price C P, Milligan T P, Darte C. Clin Chem, 1997, 43:2052-2057.
  • 10Cooper E H, Whelan P, Purves D. Prostate, 1994, 25:236-242.

共引文献99

同被引文献25

  • 1华立新,吴宏飞,眭元庚,徐正铨,张炜,钱立新,殷长军,居小兵,张杰秀.药物去势和手术去势对前列腺癌患者性激素的影响[J].中华泌尿外科杂志,2005,26(12):812-815. 被引量:12
  • 2侯龙敏,谢有兰.前列腺癌骨转移患者血清PSA测定的临床价值[J].河南大学学报(医学版),2007,26(2):70-71. 被引量:4
  • 3Lemer SE,facobsen SJ,Lilja H,et al.Free,complexed,and total serum prostate-specific antigen concentration and their proportions in predicting stage,grade,and deoxyribo,conucleic acid ploidy in patients with adenocarcinoma of the prostate[J].Urology,1996,48(2):240-248.
  • 4Yang CR,Su CK,Chiu KY,et al.Free/total prostate specific antigen ratio for prostate cancer detection:a prospective blind study[J].Anticancer Res,2005,25(3):2439-2443.
  • 5Denmeade SR,Lsaacs JT.The role of prostate-specific antigen in the clinical evaluation of prostatic disease[J].BJU Int,2004,93(Suppl 1):10-15.
  • 6Stenman UH.A complex between prostate-specific antigen and antichymotrypsin is the major form of prostate cancer:assays of the complex improves the clinical sensitivity for cancer[J].Cancer Res,1991,51(1):222-226.
  • 7Bigler SA,Deering RE,Brawer MK.Comparison of microscopic vascularity in benign and malignant prostate tissue[J].Hun pathol,1993,24(2):220-225.
  • 8Stege RH,Tribukait B,Carlstrom KA,et al.Tissue PSA from fine-needle biopsyes of prostafic carcinoma as related to serun PSA,clinical stage,cytologyical grade,and DNA ploidy[J].Prostate,1999,38(3):183-188.
  • 9Ciatto S,Bonardi R,Lombardi C,et al.predicting prostate biopsy outcome by findings at digital rectal examintion,transrectal ultrasonograply PSA,PSA density and free-to total PSA ratio in a popcilationbased screening setting[J].Int Biol Markers,2001,16(3):179-182.
  • 10Speights VO.Brawn PN Serun prostate specific an tigen levels in.non specific granulomators prostatitis[J].Br J,2005,77(3):408-410.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部